AIM 8-K: SEC filing
Filed with the SEC on · accession 0001493152-26-050093
AIM filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -5.5% by the first close after the filing.
Summary of the filing
AIM ImmunoTech furnished a corporate presentation titled 'The Ampligen Opportunity' and a related press release under Regulation FD, highlighting the potential of its drug Ampligen, including in pancreatic cancer combination treatments.
Key details
How AIM stock reacted
Close before
$0.16
Nov 4, 2026
First close after
-5.53%
$0.15
5 trading days
—
Since filing
-3.73%
$0.15
✦ Ask GOAX AI about this filing — what it means for AIM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AIM?
Click hereFrequently asked questions
What did AIM file with the SEC on Nov 5, 2026?
AIM filed a 8-K (SEC filing). AIM ImmunoTech furnished a corporate presentation titled 'The Ampligen Opportunity' and a related press release under Regulation FD, highlighting the potential of its drug Ampligen, including in pancreatic cancer combination treatments.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did AIM stock react to this filing?
AIM closed at $0.16 before the filing and $0.15 on Nov 5, 2026 (-5.53%).
Other AIM SEC filings
Get alerts when AIM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days